Market Research Reports - Ken Research Medical Devices Market Indonesia

Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research
Indonesia Healthcare market segment by hospital, pharmaceutical, pharmacy retail, clinical
laboratory and medical devices, hospital market segment (by public & private hospitals, by
general & specialty hospitals and by region), pharmaceutical market segment (by therapeutic
segment, by domestic & international players, by generic & patented drug, by OTC &
prescription drugs, by domestic sales & exports and by region), pharmacy retail market
segment (by pharmacies & drugstores and by region), clinical laboratory market segment (by
type of clinical laboratory, by type of private independent laboratory, by type of customer, by
payer, by type of test and by region) and medical device market segment (by type of medical
device, by type of medical consumables, by end user and by procurement), competitive
landscape of major players in the Indonesia hospital, pharmaceutical, pharmacy retail, clinical
laboratory and medical devices market and covering company profile of major Hospitals (Mitra
Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama,
Rumah Sakit Pondok Indah, Surya Husadha, Jakarta Eye Center), pharmaceutical companies (PT
Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia
Farma, PT Tempo Scan Pacific, PT Merck), Pharmacy Retail (Guardian Pharmacy, Kimia Farma,
Apotek K-24, A S Watsons, Century Healthcare), Diagnostic Laboratories (Prodia, Kimia Farma
Diagnostika, Pramita, Cito, BioMedika, Parahita), Medical Devices Companies (GE Healthcare
Indonesia, Siemens Indonesia, Philips Indonesia, PT Mensa Binasukses, PT Transmedic
Indonesia)
The healthcare market in Indonesia was majorly impacted by the implementation of JKN (The
Indonesian National Health Insurance) as the demand for affordable/ primary healthcare
services, generic medicines and import of medical devices increased.
Indonesia pharmaceutical market is dominated by domestic players such as PT Kalbe Farma, PT
Sanbe Farma, PT SOHO Global Health and others. The Indonesia Medical device market is
almost entirely import driven due to limited manufacturing capabilities in Indonesia.
Siloam Hospitals has the largest hospital network in the country. Public sector hospital has the
larger share in terms of number of hospitals in 2017.
Indonesia Healthcare market will be facilitated by the rising number of healthcare providers
coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis and
others. More than 35,000 new beds are likely to be added in Indonesia by 2020. Moreover, due
to the entry of new participants into the private hospital market and expansion of existing ones,
the country is expected to achieve 1.5 beds per 1,000 people by 2019.
Single specialty or multi-specialty hospitals in the country are planning to invest in advanced
medical devices to provide tertiary or super specialty treatment to the patients. For instance,